Status:
COMPLETED
Study of PRN and Every 2months Intravitreal Aflibercept for Age Related Macular Degeneration
Lead Sponsor:
Nihon University
Conditions:
Age-related Macular Degeneration
Eligibility:
All Genders
50+ years
Phase:
PHASE4
Brief Summary
Evaluate a treatment result of every two months versus as needed (PRN) after 3 initial monthly intravitreal aflibercept for the Japanese age related macular degeneration.
Eligibility Criteria
Inclusion
- Clinical diagnosis of age-related macular degeneration
Exclusion
- Any treatment before intravitreal Aflibercept for age-related macular degeneration.
- Visual acuity above 0.1 in decimal visual acuity
Key Trial Info
Start Date :
March 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2015
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT01824225
Start Date
March 1 2013
End Date
March 1 2015
Last Update
October 7 2015
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Surugadai Nihon university hospital
Chiyoda-ku, Tokyo, Japan, 101-8309